Trademark: 88672426
Status Date
Monday, June 5, 2023
Filing Date
Tuesday, October 29, 2019
Published for Opposition
Tuesday, March 10, 2020
Abandoned Date
Monday, June 5, 2023
5 Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis, and focal segmental glomerulosclerosis
Jun 5, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 5, 2023
Abandonment - No Use Statement Filed
Nov 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 15, 2022
Sou Extension 5 Granted
Nov 4, 2022
Sou Extension 5 Filed
Nov 15, 2022
Case Assigned To Intent To Use Paralegal
Nov 4, 2022
Teas Extension Received
Feb 19, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 17, 2022
Sou Extension 4 Granted
Feb 17, 2022
Sou Extension 4 Filed
Feb 17, 2022
Teas Extension Received
Nov 9, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 5, 2021
Sou Extension 3 Granted
Nov 5, 2021
Sou Extension 3 Filed
Nov 5, 2021
Teas Extension Received
May 7, 2021
Notice Of Approval Of Extension Request E-Mailed
May 5, 2021
Sou Extension 2 Granted
May 5, 2021
Sou Extension 2 Filed
May 5, 2021
Teas Extension Received
Oct 10, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 8, 2020
Sou Extension 1 Granted
Oct 8, 2020
Sou Extension 1 Filed
Oct 8, 2020
Teas Extension Received
May 5, 2020
Noa E-Mailed - Sou Required From Applicant
Mar 10, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 10, 2020
Published For Opposition
Feb 19, 2020
Notification Of Notice Of Publication E-Mailed
Feb 5, 2020
Approved For Pub - Principal Register
Feb 3, 2020
Assigned To Examiner
Nov 1, 2019
New Application Office Supplied Data Entered
Nov 1, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24